Catyalyst Pharma (CPRX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.37 --0%
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -30.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- RH (RH) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
